These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of norepinephrine in feeding behavior. Rossi J, Zolovick AJ, Davies RF, Panksepp J. Neurosci Biobehav Rev; 1982; 6(2):195-204. PubMed ID: 6285235 [Abstract] [Full Text] [Related]
4. Effects of dopamine-beta-hydroxylase inhibitors FLA-57 and FLA-63 on ethanol metabolism and aldehyde dehydrogenase activity in rats. Tottmar O, Hellström E, Holmberg K, Lindros KO. Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):198-202. PubMed ID: 7136724 [Abstract] [Full Text] [Related]
5. Interference of inhibitors of dopamine-beta-hydroxylase with uptake of monoamines by chromaffin granular membranes. Schlichter D, Da Prada M, Pletscher A. Eur J Pharmacol; 1975 Nov; 34(1):223-7. PubMed ID: 187432 [Abstract] [Full Text] [Related]
6. Some characteristics of amnesia induced by FLA-63 an inhibitor of dopamine beta hydroxylase. Botwinick CY, Quartermain D, Freedman LS, Hallock MF. Pharmacol Biochem Behav; 1977 May; 6(5):487-91. PubMed ID: 19771 [Abstract] [Full Text] [Related]
7. Induction of food intake by a noradrenergic system using clonidine and fusaric acid in the neonatal chick. Bungo T, Shimojo M, Masuda Y, Choi YH, Denbow DM, Furuse M. Brain Res; 1999 May 01; 826(2):313-6. PubMed ID: 10224312 [Abstract] [Full Text] [Related]
10. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study. Brodde OE, Nagel M, Schümann HJ. Arch Int Pharmacodyn Ther; 1977 Aug 01; 228(2):184-90. PubMed ID: 921409 [Abstract] [Full Text] [Related]
11. Effects of the dopamine-beta-hydroxylase inhibitor FLA 63 on the kinetics of elimination of amphetamine in the rat. Jonsson J, Lewander T. J Pharm Pharmacol; 1974 Nov 01; 26(11):907-9. PubMed ID: 4156566 [No Abstract] [Full Text] [Related]
12. Intracerebroventricular injection of fusaric acid attenuates the anorexia by glucagon-like peptide-1 in the neonatal chick. Bungo T, Kawakami SI, Ohgushi A, Sashihara K, Saito N, Sugahara K, Hasegawa S, Denbow DM, Furuse M. Pharmacol Biochem Behav; 2001 Nov 01; 70(2-3):251-5. PubMed ID: 11701195 [Abstract] [Full Text] [Related]
13. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia. Dolphin A, Jenner P, Marsden CD. Br J Pharmacol; 1975 Jun 01; 54(2):246P-247P. PubMed ID: 1148534 [No Abstract] [Full Text] [Related]
15. The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain. Semba J, Takahashi R. Psychiatry Res; 1985 Aug 01; 15(4):319-26. PubMed ID: 3934694 [Abstract] [Full Text] [Related]
16. Evidence that norepinephrine and epinephrine systems mediate the stimulatory effects of ovarian hormones on luteinizing hormone and luteinizing hormone-releasing hormone. Adler BA, Johnson MD, Lynch CO, Crowley WR. Endocrinology; 1983 Oct 01; 113(4):1431-8. PubMed ID: 6352246 [Abstract] [Full Text] [Related]
17. Some catecholamine inhibitors do not cause accumulation of nuclear estrogen receptors in rat hypothalamus and anterior pituitary gland. Blaustein JD, Brown TJ, McElroy JF. Neuroendocrinology; 1986 Oct 01; 43(2):143-9. PubMed ID: 2873523 [Abstract] [Full Text] [Related]